Anne-Sophie Chrétien

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

Sumin Jo, Shipra Das, Alan F. Williams et al. · Nature Communications · 2022 · 154 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma

Benjamin Bian, Daniele Fanale, Nelson Dusetti et al. · OncoImmunology · 2019 · 122 citations · Full text

Medicine, Immunology, Oncology +17

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci et al. · Frontiers in Immunology · 2017 · 68 citations · Full text

Life Sciences, Hematology, Immunology +17

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

Anne-Sophie Chrétien, Raynier Devillier, Samuel Granjeaud et al. · Proceedings of the National Academy of Sciences · 2021 · 60 citations · Full text

Life Sciences, Hematology, Immunology +16

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

A. Benyamine, Céline Loncle, Etienne Foucher et al. · OncoImmunology · 2017 · 55 citations · Full text

Medicine, Immunology, Oncology +13